Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Motor Neuron Disease, Amyotrophic Lateral Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07127172
What this trial is testing

GB-PRIME: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices

Who this might be right for
Tetraplegia/TetraparesisQuadriplegiaQuadriplegia/Tetraplegia+6 more
Neuralink Corp 7
Testing effectiveness (Phase 2)Study completedNCT02039401
What this trial is testing

Safety Study of VM202 to Treat Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Helixmith Co., Ltd. 18
Not applicableUnknownNCT00420719
What this trial is testing

Motor-Point Stimulation for Conditioning the Diaphragm of Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Synapse Biomedical 100
Not applicableStudy completedNCT02236897
What this trial is testing

PET Imaging in ALS Patients

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Johns Hopkins University 36
Testing effectiveness (Phase 2)Looking for participantsNCT07287397
What this trial is testing

Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Vector Y Therapeutics 12
Testing effectiveness (Phase 2)Study completedNCT01786603
What this trial is testing

Rasagiline in Subjects With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Richard Barohn, MD 80
Early research (Phase 1)Study completedNCT05006352
What this trial is testing

Determine the Safety, Pharmacokinetics, and Pharmacodynamics of DNL343 in Participants With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Denali Therapeutics Inc. 29
Not applicableStudy completedNCT04800926
What this trial is testing

Xavier Electromyographic Wheelchair Control for Limited Mobility Patients

Who this might be right for
Amyotrophic Lateral Sclerosis
Mayo Clinic 4
Not applicableLooking for participantsNCT07334743
What this trial is testing

Identifying Biomarkers in ALS Patients Using Neuronal Derived Extracellular Vesicles

Who this might be right for
Amyotrophic Lateral SclerosisENGRAILED1
Fondation Ophtalmologique Adolphe de Rothschild 60
Testing effectiveness (Phase 2)Looking for participantsNCT07071935
What this trial is testing

A Clinical Trial of Early Ventilation in Amyotrophic Lateral Sclerosis (EVENT ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)Chronic Respiratory FailureNeuromuscular Disease Patients+7 more
University of Pennsylvania 48
Not applicableStudy completedNCT01123148
What this trial is testing

A P300 Brain Computer Interface to Operate Power Wheelchair Tilt

Who this might be right for
HealthyAmyotrophic Lateral Sclerosis
University of Michigan 16
Large-scale testing (Phase 3)Study completedNCT00706147
What this trial is testing

Phase II/III Randomized, Placebo-controlled Trial of Arimoclomol in SOD1 Positive Familial Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
University of Miami 38
Large-scale testing (Phase 3)Active Not RecruitingNCT04057898
What this trial is testing

Evaluation of MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients With ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
MediciNova 234
Early research (Phase 1)Active Not RecruitingNCT03651349
What this trial is testing

To Determine the Maximum Tolerated Dose (MTD) of HK-001 in Healthy Volunteers

Who this might be right for
Amyotrophic Lateral Sclerosis
Everfront Biotech Co., Ltd. 56
Not applicableUnknownNCT03811301
What this trial is testing

[BrainConnexion] - Neurodevice Phase I Trial

Who this might be right for
TetraplegiaTetraplegia/TetraparesisSpinal Cord Injuries+4 more
National Neuroscience Institute 5
Large-scale testing (Phase 3)Study completedNCT02496767
What this trial is testing

Ventilatory Investigation of Tirasemtiv and Assessment of Longitudinal Indices After Treatment for a Year

Who this might be right for
Amyotrophic Lateral Sclerosis
Cytokinetics 744
Not applicableStudy completedNCT04440644
What this trial is testing

Italian Validation of the Beaumont Behavioural Inventory (BBI)

Who this might be right for
Amyotrophic Lateral Sclerosis
Istituti Clinici Scientifici Maugeri SpA 190
Not applicableStudy completedNCT02750982
What this trial is testing

Laughter Therapy Effects on Mood, Stress and Self-efficacy in People With Neurological Diseases.

Who this might be right for
Alzheimer's DiseaseAmyotrophic Lateral SclerosisBrain Injury+5 more
Brown, Theodore R., M.D., MPH 24
Testing effectiveness (Phase 2)Study completedNCT05163886
What this trial is testing

Study of Safety, Tolerability, and Biological Activity of LAM-002A in C9ORF72-Associated Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral SclerosisALS
OrphAI Therapeutics 14
Not applicableLooking for participantsNCT03233646
What this trial is testing

Retinal Imaging in Neurodegenerative Disease

Who this might be right for
Alzheimer's DiseaseMild Cognitive ImpairmentParkinson's Disease+12 more
Duke University 2,000
Next Page